TOKYO -- Fujifilm Holdings has joined hands with German drugmaker Bayer to develop an immune-based cancer treatment using induced pluripotent stem cells.
Pharmaceuticals
Fujifilm teams up with Bayer on cancer drug development
Companies to test cheaper stem cell-based immunotherapy drug for cancer patients
Japan's Fujifilm and Germany's Bayer are collaborating on tests that could make a promising cancer treatment more affordable.
Read Next
Latest on Pharmaceuticals
